NCT02229838View on ClinicalTrials.gov

Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics of BIBB 1464 MS in Healthy Male Subjects, Combined With Preliminary Evaluation of Relative Bioavailability and Effect of Food

PHASE1CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

July 31, 1999

Primary Completion Date

September 30, 1999

Conditions
Healthy
Interventions
DRUG

BIBB 1464 MS tablet

DRUG

BIBB 1464 MS solution

DRUG

BIBB 1464 MS placebo

OTHER

Standard dinner

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY